130 related articles for article (PubMed ID: 25210406)
1. Acute delirium in an elderly woman following zoledronate administration.
Nasiruddin M; Fayazuddin M; Zahid M; Iftekhar S
J Pharmacol Pharmacother; 2014 Jul; 5(3):217-9. PubMed ID: 25210406
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonate-induced Severe Hypocalcemia - A Case Report -.
Do WS; Park JK; Park MI; Kim HS; Kim SH; Lee DH
J Bone Metab; 2012 Nov; 19(2):139-45. PubMed ID: 24524045
[TBL] [Abstract][Full Text] [Related]
3. Valproate-induced delirium in a demented patient.
Gareri P; Lacava R; Cotroneo A; Bambara V; Marigliano N; Castagna A; Costantino DS; Ruotolo G; de Sarro G
Arch Gerontol Geriatr; 2009; 49 Suppl 1():113-8. PubMed ID: 19836623
[TBL] [Abstract][Full Text] [Related]
4. Persistence with intravenous zoledronate in elderly patients with osteoporosis.
Lee YK; Nho JH; Ha YC; Koo KH
Osteoporos Int; 2012 Sep; 23(9):2329-33. PubMed ID: 22179417
[TBL] [Abstract][Full Text] [Related]
5. Zoledronate Therapy for the Pathological Humeral Fracture in Polyostotic Fibrous Dysplasia: A Case Report.
Ohno I; Higuchi C
J Clin Med Res; 2015 Nov; 7(11):901-6. PubMed ID: 26491505
[TBL] [Abstract][Full Text] [Related]
6. Orbital inflammatory disease in a patient treated with zoledronate.
Kaur H; Uy C; Kelly J; Moses AM
Endocr Pract; 2011; 17(4):e101-3. PubMed ID: 21803720
[TBL] [Abstract][Full Text] [Related]
7. Separate episodes of delirium associated with levetiracetam and amiodarone treatment in an elderly woman.
Foley KT; Bugg KS
Am J Geriatr Pharmacother; 2010 Apr; 8(2):170-4. PubMed ID: 20439066
[TBL] [Abstract][Full Text] [Related]
8. The incidence of acute anterior uveitis after intravenous zoledronate.
Patel DV; Horne A; House M; Reid IR; McGhee CN
Ophthalmology; 2013 Apr; 120(4):773-6. PubMed ID: 23290982
[TBL] [Abstract][Full Text] [Related]
9. Early onset acute tubular necrosis following single infusion of zoledronate.
Yachoui R
Clin Cases Miner Bone Metab; 2016; 13(2):154-156. PubMed ID: 27920815
[TBL] [Abstract][Full Text] [Related]
10. Zoledronate once-yearly increases bone mineral density--implications for osteoporosis.
Doggrell SA
Expert Opin Pharmacother; 2002 Jul; 3(7):1007-9. PubMed ID: 12083999
[TBL] [Abstract][Full Text] [Related]
11. The three-year effect of a single zoledronate infusion on bone mineral density and bone turnover markers following denosumab discontinuation in women with postmenopausal osteoporosis.
Makras P; Papapoulos SE; Polyzos SA; Appelman-Dijkstra NM; Anastasilakis AD
Bone; 2020 Sep; 138():115478. PubMed ID: 32534221
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial comparing efficacies of zoledronate and alendronate for improving bone mineral density and inhibiting bone remodelling in women with post-menopausal osteoporosis.
Tan W; Sun J; Zhou L; Li Y; Wu X
J Clin Pharm Ther; 2016 Oct; 41(5):519-23. PubMed ID: 27440710
[TBL] [Abstract][Full Text] [Related]
13. Postoperative mental status in elderly hip surgery patients.
Jagmin MG
Orthop Nurs; 1998; 17(6):32-42. PubMed ID: 10095647
[TBL] [Abstract][Full Text] [Related]
14. Zoledronate induces bisphosphonate-related osteonecrosis of the jaw in osteopenic sheep.
Voss PJ; Stoddart MJ; Bernstein A; Schmelzeisen R; Nelson K; Stadelmann V; Ziebart T; Poxleitner PJ
Clin Oral Investig; 2016 Jan; 20(1):31-8. PubMed ID: 25843053
[TBL] [Abstract][Full Text] [Related]
15. Clinical research update: zoledronate.
Body JJ
Cancer; 1997 Oct; 80(8 Suppl):1699-701. PubMed ID: 9362440
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic Encephalopathy in a Patient With Metastatic Lung Cancer: A Case Study.
Rowley SM
J Adv Pract Oncol; 2018 Mar; 9(2):216-221. PubMed ID: 30588355
[No Abstract] [Full Text] [Related]
17. Intravenous zoledronate for osteoporosis: less might be more.
Grey A
Ther Adv Musculoskelet Dis; 2016 Aug; 8(4):119-23. PubMed ID: 27493690
[TBL] [Abstract][Full Text] [Related]
18. Zoledronate Induced Hypocalcemia and Hypophosphatemia in Osteoporosis: A Cause of Concern.
Kaur U; Chakrabarti SS; Gambhir IS
Curr Drug Saf; 2016; 11(3):267-9. PubMed ID: 27113952
[TBL] [Abstract][Full Text] [Related]
19. Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates.
Sánchez A; Blanco R
Osteoporos Int; 2017 Mar; 28(3):1145-1147. PubMed ID: 27866217
[TBL] [Abstract][Full Text] [Related]
20. A dose-finding study of zoledronate in hypercalcemic cancer patients.
Body JJ; Lortholary A; Romieu G; Vigneron AM; Ford J
J Bone Miner Res; 1999 Sep; 14(9):1557-61. PubMed ID: 10469284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
